0001691221 2023-01-01 2023-06-30 0001691221 2023-06-30 0001691221 2022-12-31 0001691221 2022-01-01 2022-06-30 0001691221 2023-04-01 2023-06-30 0001691221 2022-04-01 2022-06-30 0001691221 us-gaap:CommonStockMember 2021-12-31 0001691221 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001691221 us-gaap:RetainedEarningsMember 2021-12-31 0001691221 us-gaap:ParentMember 2021-12-31 0001691221 us-gaap:NoncontrollingInterestMember 2021-12-31 0001691221 2021-12-31 0001691221 us-gaap:CommonStockMember 2022-12-31 0001691221 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001691221 us-gaap:RetainedEarningsMember 2022-12-31 0001691221 us-gaap:ParentMember 2022-12-31 0001691221 us-gaap:NoncontrollingInterestMember 2022-12-31 0001691221 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001691221 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001691221 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001691221 us-gaap:ParentMember 2022-01-01 2022-12-31 0001691221 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001691221 2022-01-01 2022-12-31 0001691221 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001691221 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001691221 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001691221 us-gaap:ParentMember 2023-01-01 2023-06-30 0001691221 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-06-30 0001691221 us-gaap:CommonStockMember 2023-06-30 0001691221 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001691221 us-gaap:RetainedEarningsMember 2023-06-30 0001691221 us-gaap:ParentMember 2023-06-30 0001691221 us-gaap:NoncontrollingInterestMember 2023-06-30 0001691221 2023-03-31 0001691221 2022-03-31 0001691221 2022-06-30 0001691221 2017-06-15 2017-06-15 0001691221 2023-03-29 0001691221 2023-05-31 0001691221 2023-05-31 2023-05-31 0001691221 FRSX:BoardOfDirectorsMember 2023-05-31 0001691221 FRSX:BoardOfDirectorsMember 2023-05-31 2023-05-31 0001691221 FRSX:BoardOfDirectorsMember 2023-01-01 2023-06-30 0001691221 us-gaap:SubsequentEventMember 2023-07-17 2023-07-17 0001691221 srt:MinimumMember us-gaap:SubsequentEventMember 2023-07-17 2023-07-17 0001691221 us-gaap:SubsequentEventMember 2023-07-27 0001691221 us-gaap:SubsequentEventMember 2023-07-27 2023-07-27 0001691221 FRSX:BoardOfDirectorsMember us-gaap:SubsequentEventMember 2023-07-27 0001691221 FRSX:BoardOfDirectorsMember us-gaap:SubsequentEventMember 2023-07-27 2023-07-27 0001691221 FRSX:AmericanDepositorySharesMember FRSX:JanuaryTwoThousandTwentyOneSalesAgreementMember 2021-01-21 2021-01-22 0001691221 FRSX:AmericanDepositorySharesMember 2023-05-19 0001691221 FRSX:AmericanDepositorySharesMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-08-01 2023-08-31 0001691221 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-08-01 2023-08-31 0001691221 FRSX:AmericanDepositorySharesMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-08-31 iso4217:USD shares iso4217:USD shares FRSX:Employee iso4217:ILS iso4217:ILS shares pure 6-K 001-38094 FORESIGHT AUTONOMOUS HOLDINGS LTD. 7 Golda Meir Ness Ziona 7403650 IL 0001691221 false Q2 --12-31 2023 2023-06-30 FORESIGHT AUTONOMOUS HOLDINGS LTD. 6-K

17033000

19173000

97000

102000

662000

7216000

2000

569000

842000

18363000

27335000

2056000

2156000

1260000

2804000

575000

598000

3891000

5558000

22254000

32893000

242000

315000

456000

527000

1297000

1792000

1995000

2634000

1370000

1476000

3365000

4110000

1000000000

322979556

130453000

129810000

-112131000

-101480000

18322000

28330000

567000

453000

18889000

28783000

22254000

32893000

55000

248000

213000

21000

117000

90000

34000

131000

123000

6269000

5498000

3150000

2806000

1188000

1229000

484000

605000

1573000

2025000

715000

837000

-8996000

-8621000

-4349000

-4125000

-1655000

-3519000

-1715000

-5991000

-10651000

-12140000

-6064000

-10116000

-0.03

-0.04

-0.02

-0.03

322979556

322776209

322979556

322784556

322652016

128209000

-79804000

48405000

228000

48633000

7540

4000

320000

1597000

225000

1822000

-21676000

322979556

129810000

-101480000

28330000

453000

28783000

322979556

129810000

-101480000

28330000

453000

28783000

643000

114000

757000

-10651000

322979556

130453000

-112131000

18322000

567000

18889000

322979556

130453000

-112131000

18322000

567000

18889000

-10651000

-12140000

-6064000

-10116000

2668000

4033000

2555000

6838000

-7983000

-8107000

-3509000

-3278000

-6554000

-7008000

6000

-3074000

1001000

714000

101000

249000

17000

70000

6453000

5758000

-23000

2290000

-615000

-713000

-335000

-720000

-2145000

-3062000

-3867000

-1708000

19275000

28188000

20997000

26834000

17130000

25126000

17130000

25126000

757000

949000

412000

453000

125000

106000

65000

55000

1544000 2796000 1666000 5589000 615000 713000 335000 720000

-362000

-88000

-184000

-355000

-73000

-2000

-19000

-30000

-166000

-292000

-127000

-233000

-496000

-325000

39000

-71000

2668000

4033000

2555000

6838000

256000

229000

128000

118000

141000

31000

<p id="xdx_804_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zKGbLLz5Js9f" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.5in">NOTE 1</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 0.25in">-</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">GENERAL</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">Reporting Entity</td></tr> </table> Foresight Autonomous Holdings Ltd. (the “Company”) is an Israeli resident company incorporated in Israel. The address of the Company’s registered office is 7 Golda Meir St., Ness Ziona, Israel. The unaudited condensed consolidated interim financial statements of the Company as of June 30, 2023, comprise the Company and its fully owned subsidiaries in Israel and China (together referred to as the “Group”). The Company, through of its subsidiaries, Foresight Automotive Ltd. (“Foresight Automotive”) and Foresight Changzhou Automotive Ltd. (“Foresight Changzhou”), is a technology company developing smart multi-spectral vision software solutions including modules of automatic calibration and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. In addition, the Company, through of its subsidiary, Eye-Net Mobile Ltd. (“Eye-Net Mobile”) is also engaged in the development of a cellular-based solution suite that provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge artificial intelligence (“AI”) technology and advanced analytics. The ordinary shares of the Company, no par value each (the “Ordinary Shares”), are registered for trade on the Tel Aviv Stock Exchange Ltd. In addition, since June 15, 2017, the Company has American Depository Shares (“ADSs”) registered with the U.S. Securities and Exchange Commission. The ADSs are listed on The Nasdaq Capital Market; the ratio of the Company’s Ordinary Shares to ADSs is 30:1. The Group activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize its technology before competitors develop similar technology. In addition, the Group is subject to risks from, among other things, competition associated with the industry in general, other risks associated with financing, liquidity requirements, rapidly changing customer requirements and limited operating history. To date, the Company has not generated significant revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate significant operational losses and to continue to fund operations primarily through the utilization of its current financial resources, sales of its products, and through additional raises of capital. The Company anticipates its existing cash will be sufficient to fund its expected operating cash requirements for at least twelve months following the date of this report.

The ADSs are listed on The Nasdaq Capital Market; the ratio of the Company’s Ordinary Shares to ADSs is 30:1.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.5in">NOTE 2</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 0.25in">-</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">Unaudited Interim Financial Statements</td></tr> </table> The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of the management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2022. The results of operation for the six and three months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">Significant Accounting Policies</td></tr> </table> The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements. FORESIGHT AUTONOMOUS HOLDINGS LTD. U.S. dollars in thousands (Except share and per share data and exercise prices) Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">Use of estimates</td></tr> </table> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">Unaudited Interim Financial Statements</td></tr> </table> The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of the management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2022. The results of operation for the six and three months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">Significant Accounting Policies</td></tr> </table> The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements. FORESIGHT AUTONOMOUS HOLDINGS LTD. U.S. dollars in thousands (Except share and per share data and exercise prices) Notes to the Interim Condensed Consolidated Financial Statements (Unaudited)

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">Use of estimates</td></tr> </table> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.5in">NOTE 3</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 0.25in">-</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">MATERIAL EVENTS IN THE REPORTING PERIOD</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On March 29, 2023, the Company issued options to purchase 375,000 Ordinary Shares to its employees at an exercise price of NIS 1 ($0.27). The options shall vest over a period of three years until fully vested. During the six months ended June 30, 2023, the Company recorded in its statement of comprehensive loss a total expense of $2 in respect of those grants.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On April 6, 2023, the Company announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its Ordinary Shares (the “ADS Ratio”), no par value per share, from ADS Ratio of one (1) ADS to five (5) Ordinary Shares, to a new ADS Ratio of one (1) ADS to thirty (30) Ordinary Shares (the “ADS Ratio Change”). The ADS Ratio Change was effective on April 21, 2023.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On May 31, 2023, the Company issued options to purchase 150,000 Ordinary Shares to its employees at an exercise price of NIS 0.5 ($0.13). The options shall vest over a period of three years until fully vested.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">D.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On May 31, 2023, the Company’s Board of Directors approved a decrease in the exercise price of all options previously granted to all employees to NIS <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uILSPShare_c20230531__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zw1aPMsc9KN6" title="Exercise price per share">0.5 ($<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230531__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_zi3PVAEm2ss7" title="Exercise price per share">0.13), (“Repricing”). The Repricing amounted to $174 which will vest over the reminding vesting period of each option. During the six months ended June 30, 2023, the Company recorded in its statement of comprehensive loss a total expense of $73 in respect of the repricing.</td></tr> </table>

375000

0.27

P3Y

2000

150000

0.5

0.13

P3Y

0.5

0.13

174000

73000

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed; width: 0.5in">NOTE 4</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; unicode-bidi: embed; width: 0.25in">-</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">SUBSEQUENT EVENTS</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify; unicode-bidi: embed"></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left; unicode-bidi: embed">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On July 17, 2023, the Company announced the signing of an exclusive commercialization agreement with Elbit Systems Land Ltd. (“Elbit”), a subsidiary of Elbit Systems Ltd. (Nasdaq and TASE: ESLT), for the integration, marketing, and licensing of the Company’s image processing software solution. The Company expects revenues of up to $4 million, over a contractual period of five years, with minimum guaranteed revenues of $1 million over that time period. The Company expects that it will start recognizing initial revenues from its agreement with Elbit during the second half of 2023. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On July 27, 2023, the Company convened an annual and extraordinary general meeting of shareholders (“the annual meeting”) which approved the Company to issue options to purchase 800,000 Ordinary Shares to its two of its directors at an exercise price of NIS <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uILSPShare_c20230727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrsYzznJ3Fpl" title="Exercise price per share">0.5 ($<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVCXqNfTRGP4" title="Exercise price per share">0.13). The options shall vest over a period of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20230727__20230727__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRjCnDHfrkn5" title="Fully vested">three years until fully vested. Also, the annual meeting approved a decrease in the exercise price of all options previously granted to all members of the Board of Directors, to the Company’s Chief Executive Officer, VP Human Resources and employees of the Company’s significant shareholder, Magna B.S.P Ltd., to NIS <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uILSPShare_c20230727__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxKpkmondc6j" title="Exercise price per share">0.5 ($<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20230727__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFpJC5qYW3gg" title="Exercise price per share">0.13), (“Repricing”). The Repricing amounted to $<span id="xdx_906_ecustom--VestedOptions_c20230727__20230727__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0x6SC1QA5mc" title="Vested options">101 which will vest over the reminding vesting period of each option.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">On January 22, 2021, the Company entered into a sales agreement, pursuant to which the Company can sell from time to time, ADSs, in the aggregated amount of up to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20210121__20210122__us-gaap--AwardTypeAxis__custom--AmericanDepositorySharesMember__us-gaap--TypeOfArrangementAxis__custom--JanuaryTwoThousandTwentyOneSalesAgreementMember_z2NbqnTvRgZ4" title="Aggregated amount">60,000 (the “January 2021 Sales Agreement”). Sales under the January 2021 Sales Agreement were made by any method permitted by law that is deemed to be an “at the market” offering as defined in Rule 415 promulgated under the Securities Act. On May 19, 2023, the aggregate offering price was reduced to $14,000 due to applicable securities law restrictions resulting from a decrease in the value of the public float of the Company’s ADSs. During August 2023 the Company issued a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230801__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__custom--AmericanDepositorySharesMember_zw9GGv9pYx0c" title="Issuance of ordinary shares">26,950 ADSs (<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230801__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zflkmAxrc5Ff" title="Issuance of ordinary shares">808,500 Ordinary Shares) at an average of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__custom--AmericanDepositorySharesMember_zJGkWcONnQY4" title="Shares issued, price per share">3.071 per ADS. After deducting closing costs and fees, the Company received net proceeds of approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20210121__20210122__us-gaap--AwardTypeAxis__custom--AmericanDepositorySharesMember__us-gaap--TypeOfArrangementAxis__custom--JanuaryTwoThousandTwentyOneSalesAgreementMember_zLo3CEpBuHba" title="Net proceeds from sales of stock">80, net of issuance expenses.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; unicode-bidi: embed">D.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; unicode-bidi: embed">During August 2023, Eye-Net Mobile and Pango Pay & Go Ltd. (“Pango”) have agreed to postpone the integration process of Eye-Net™ Protect products into Pango’s application to the second quarter of 2024 due to internal changes in Pango.</td></tr> </table>

4000000

P5Y

1000000

800000

0.5

0.13

P3Y

0.5

0.13

101000

60000000

14000000

26950

808500

3.071

80000